← All companies
Intellia Therapeutics, Inc.
NTLA - CIK 0001652130
Market cap$1.73 B
Rank#2213
SEC filings687
The table below shows Intellia Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $155.46M | $189.18M | $226.75M | $523.51M | $123.41M | $160.02M |
| Short-term investments | $294.42M | $412.33M | $685.48M | $669.12M | $625.28M | $437.35M |
| Receivables | $9.47M | $8.52M | $36.46M | $3.77M | $2.03M | $2.13M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.